1. Home >
  2. Companies >
  3. Life Science >
  4. India >
  5. Lupin

Lupin - M&A Summary and Business Overview

Life ScienceCompany

Lupin M&A Summary

Lupin has acquired 11 companies, including 3 in the last 5 years. It has also divested 2 assets.

Lupin’s largest acquisition to date was in 2017, when it acquired Symbiomix Therapeutics for $150M. Lupin has acquired in 3 different US states, and 7 countries. The Company’s most targeted sectors include life science (82%) and medical products (19%).

Lupin Business Overview

Where is Lupin headquartered?

Lupin is headquartered in Mumbai, India.

What is Lupin’s revenue?

Lupin disclosed revenue of 196,563M INR for 2024 and 162,700M INR for 2023.

How many employees does Lupin have?

Lupin has 19,210 employees.

What sector is Lupin in?

Lupin is a life science company.

When was Lupin founded?

Lupin was founded in 1968.

M&A Summary

  • M&A Total Activity12
    • M&A Buy Activity10
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 4

Lupin

Lupin Ltd.

Kalpataru Inspire 3rd Floor Off. Western Expressway Highway Santacruz (East),
Mumbai, 400055
India,
+91 22 6640 2323
www.lupin.com

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, India.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.4/yr) # 8 - - - 1 1 10
vol $150M $150M
Sell (0.2/yr) # 1 - - - 1 - 2
  12

Most Recent M&A

Company Date Value Type
Renascience Pharma Ltd. 2025-04-02 - Add-on Acquisition
Luton, United Kingdom · www.renasciencepharma.com
Eli Lilly - Huminsulin 2024-12-30 - Divestiture
Indianapolis, Indiana
Lupin Ltd. - U.S. Commercial Women's Health Specialty Business 2024-07-15 - Divestiture
Baltimore, Maryland
Kyowa Pharmaceutical Industry Co. Ltd. 2019-11-11 - Secondary Sale
Osaka, Japan · www.kyowayakuhin.co.jp
Symbiomix Therapeutics LLC 2017-10-11 150M USD Add-on Acquisition
Newark, New Jersey · www.symbiomix.com
GAVIS Pharmaceuticals LLC 2016-03-09 - Add-on Acquisition
Somerset, New Jersey · www.gavispharma.com
Novel Laboratories, Inc. 2016-03-09 - Add-on Acquisition
Somerset, New Jersey · www.novellabs.net
Temmler Pharma GmbH & Co. KG 2015-07-24 - Divestiture
Marburg, Germany
Biocom ZAO 2015-07-02 - Add-on Acquisition
, Russia
Laboratorios Grin S.A. de C.V. 2014-09-30 - Add-on Acquisition
Mexico City, Mexico · www.laboratoriosgrin.com.mx
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (82%) 150M (100%) 2 (100%) -
Medical Products 2 (18%) - - -
Total 11 $150M 2 -

By Geo

State/Country Buy Value Sell Value
United States 5 150M 1 -
  New Jersey 3 150M - -
  Maryland 1 - 1 -
  Indiana 1 - - -
Japan 1 - 1 -
Germany 1 - - -
Mexico 1 - - -
Netherlands 1 - - -
Russia 1 - - -
United Kingdom 1 - - -
Domestic - - - -
Cross-border 11 (100%) 150M (100%) 2 (100%) -
Total 11 $150M 2 -

Deal Values

buy # Total
$100M to $1B 1 $150M
TOTAL $150M
Largest Symbiomix Therapeutics LLC
$150M (2017-10-11)

M&A Connections

Deals
Acquired from
Strategic(s)
27%
3 (27%)
Divested to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

Company Summary

SECTOR

Life Science

Revenue

196,563   21% 2024
162,700   1% 2023
161,928   9% 2022
149,270   2% 2021
151,428   8% 2020
163,694   6% 2019
155,522   2018
(millions of INR) Show More Show Less

Employees

19,210

Established

1968

Public

National Stock Exchange of India (NSE): LUPIN

Former Name

Lupin Chemicals Ltd.

 Subscribe to unlock this and 214,646
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Lupin

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal